BioRem Inc. Cash Flow Quality Index

Latest as of June 2026: -1.42x

BioRem Inc. cash flow quality index. BioRem Inc. (BRM) has a Cash Flow Quality Index of -1.42x as of June 2026. Operating cash flow of CA$-2.82 Million is below net income of CA$1.98 Million, suggesting accrual-heavy earnings not yet converted to cash. See BioRem Inc. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.42x
Operating CF / Net Income

Operating Cash Flow

CA$-2.82 Million
CAD

Net Income

CA$1.98 Million
CAD

Data as of

Jun 2026
Most recent filing

Cash Flow Quality Index of BioRem Inc. (2003–2025)

Cash flow quality index of BioRem Inc. from 2003 to 2025. Historical Cash Flow Quality Index for BioRem Inc. across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can BioRem Inc. service its debt to assess how comfortably operating cash covers total debt obligations.

BioRem Inc. Cash Flow Quality Index by Year (2003–2025)

BioRem Inc. cash flow quality index by year from 2003 to 2025. Year-by-year earnings quality comparison for BioRem Inc.. For the full cash flow conversion analysis, see BioRem Inc. (BRM) cash conversion ratio.

Year Quality Index Operating CF (CAD) Net Income YoY Change
2025 1.59x CA$7.64 Million CA$4.82 Million ▲ +31.0%
2024 1.21x CA$3.69 Million CA$3.04 Million ▲ +438.5%
2023 0.22x CA$490.03K CA$2.18 Million ▼ -74.9%
2022 0.90x CA$1.44 Million CA$1.61 Million ▼ -69.3%
2021 2.92x CA$3.78 Million CA$1.30 Million ▲ +82.6%
2020 1.60x CA$3.34 Million CA$2.09 Million ▲ +295039.2%
2018 0.00x CA$-2.53K CA$4.67 Million ▼ -100.1%
2017 0.77x CA$1.17 Million CA$1.53 Million ▲ +154.0%
2016 -1.42x CA$-777.78K CA$547.27K ▼ -211.7%
2015 1.27x CA$2.15 Million CA$1.69 Million ▲ +24.5%
2013 1.02x CA$733.71K CA$717.62K ▲ +125.6%
2005 -4.00x CA$-1.37 Million CA$343.89K ▼ -2592.0%
2003 -0.15x CA$-285.98K CA$1.93 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.